Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/19/1/68/432916/mdm358.pdf
Reference19 articles.
1. Polychemotherapy for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group;Lancet,1998
2. Tamoxifen for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group;Lancet,1998
3. Do we really need prognostic factors for breast cancer?;Clark;Breast Cancer Res Treat,1994
4. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?;Colozza;Ann Oncol,2005
5. Cyclin E and survival in patients with breast cancer;Keyomarsi;N Engl J Med,2002
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells;Medical Oncology;2024-08-08
2. A new framework for exploratory network mediator analysis in omics data;Genome Research;2024-05-07
3. In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents;International Journal of Molecular Sciences;2023-09-06
4. PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions;Cell Death & Differentiation;2023-02-23
5. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3